Your browser doesn't support javascript.
loading
Inhibition of miR-34b and miR-34c enhances α-synuclein expression in Parkinson's disease.
Kabaria, Savan; Choi, Doo Chul; Chaudhuri, Amrita Datta; Mouradian, M Maral; Junn, Eunsung.
Afiliação
  • Kabaria S; Center for Neurodegenerative and Neuroimmunologic Diseases, Department of Neurology, Rutgers - Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
  • Choi DC; Center for Neurodegenerative and Neuroimmunologic Diseases, Department of Neurology, Rutgers - Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
  • Chaudhuri AD; Center for Neurodegenerative and Neuroimmunologic Diseases, Department of Neurology, Rutgers - Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
  • Mouradian MM; Center for Neurodegenerative and Neuroimmunologic Diseases, Department of Neurology, Rutgers - Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA.
  • Junn E; Center for Neurodegenerative and Neuroimmunologic Diseases, Department of Neurology, Rutgers - Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA. Electronic address: junneu@rwjms.rutgers.edu.
FEBS Lett ; 589(3): 319-25, 2015 Jan 30.
Article em En | MEDLINE | ID: mdl-25541488

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / MicroRNAs / Alfa-Sinucleína Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / MicroRNAs / Alfa-Sinucleína Limite: Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article